FRANKLIN, Massachusetts, May 13, 2015, /PRNewswire/ —
For the first time, the company will manage and coordinate all stages of diagnosis and treatment for hospitals
In light of the growing evidence of the link between cardiovascular disease and obstructive sleep apnea (OSA), Itamar Medical Ltd. (TASE: ITMR) is expanding its business model by offering a comprehensive sleep apnea management program to cardiologists, who seek to create a streamlined pathway for effective treatment. Itamar Medical markets the WatchPAT™ home sleep test and now offers a solution to manage the entire OSA care continuum for hospitals and clinics.